What has Droia Ventures invested in recently?

Recent investments include Vaderis Therapeutics AG, Unnatural Products Inc. and Protego Biopharma, Inc.. It made 2 investments in the last 12 months.

Where is Droia Ventures based?

Droia Ventures is headquartered in Brussels, Belgium. It has 2 other offices.

How do I contact Droia Ventures?

Partner names, emails and LinkedIn profiles for Droia Ventures are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

Droia Ventures

Venture Capital FirmBrussels, BelgiumFounded 2011droiaventures.com

Est. dry powder

$30M

Raised, not yet invested

AUM

—

Not reported

Latest fund

$265M

Droia Genetic Disease

Est. cheque size

$2.7M–$13.3M

From fund sizes

Deals, last 12 months

Last seen investing Aug 2026

About Droia Ventures

Droia Ventures is a Belgium-based private equity firm that focuses on developing oncology therapies. The firm makes select investments in early-stage drug development biotech companies across the Globe. The firm operates from the offices in Luxembourg and Belgium.

Type: Venture Capital Firm
Headquarters: Brussels, Belgium
Stages: SeedSeries ASeries BSeries CEarly Stage
Est. cheque size: $2.7M–$13.3M
Sectors: Healthcare
Regions: Europe
Strategies: Pre-Seed, Seed, Series A

Where they invest

From deals and portfolio companies on record

Most frequent rounds

Series A12
Series B12
Series C6
Seed3

Across 36 deals

Portfolio sectors

Biotechnology20
Pharmaceuticals3

Across 23 companies

Portfolio countries

US14
Netherlands3
Belgium2
Denmark1
Singapore1

Across 23 companies

Recent investments

Newest 5 of 36

Aug 2026
Vaderis Therapeutics AG
Aug 2026 · Series B
Series B$152MGoldman Sachs Asset Management, EQT Life Sciences, Omega Funds, Perceptive Advisors +3
Mar 2026
Unnatural Products Inc.
Mar 2026 · Series B
Series B$45MMerck Global Health Innovation Fund, ARTIS Ventures, argenx SE, The Venture Collective +1
Oct 2025
Protego Biopharma, Inc.
Oct 2025 · Series B
Series B$32.9MLightspeed Venture Partners, Novartis Venture Fund, Forbion, MPM BioImpact +5
Jun 2025
Actio Biosciences, Inc.
Jun 2025 · Series B
Series B$66MCanaan Partners, Deerfield Management, Euclidean Capital, Regeneron Ventures
Jan 2025
Alesta Therapeutics
Jan 2025 · Series A
Series A$66.9MNovartis Venture Fund, Thuja Capital, RTW Investments, SSI Strategy Holdings LLC +2

Offices

3 locations

Brussels, BelgiumHQ
Luxembourg, Luxembourg
Leuven, Belgium

Questions about Droia Ventures

How much does Droia Ventures invest per deal?

Based on the size of its funds, Droia Ventures writes estimated cheques of $2.7M–$13.3M. Lead cheques usually sit at the top of that range and follow-on cheques lower.

What stages does Droia Ventures invest in?

Droia Ventures has invested at Seed, Series A, Series B, Series C and Early Stage. Its most frequent rounds on record are Series A, Series B and Series C.

How much capital does Droia Ventures have left to invest?

Droia Ventures has an estimated $30M in dry powder: capital it has raised but not yet invested.

Similar investors in Europe

Index VenturesUK · Cheque $2.5M–$30M$4B dry powder ForbionNetherlands · Cheque $2.3M–$35.1M$2.4B dry powder European Investment Bank